Statement of Changes in Beneficial Ownership (4)
July 02 2021 - 5:09PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
WOLF DALE B |
2. Issuer Name and Ticker or Trading Symbol
MOLINA HEALTHCARE, INC.
[
MOH
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below)
|
(Last)
(First)
(Middle)
2180 HARVARD STREET, SUITE 400 |
3. Date of Earliest Transaction
(MM/DD/YYYY)
7/1/2021 |
(Street)
SACRAMENTO, CA 95815
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security (Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code (Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock | 7/1/2021 | | A(1) | | 215 (2) | A | $256.05 (3) | 9092 | D | |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Stock Option (Right to Buy) | $33.02 | | | | | | | (4) | 3/11/2023 | Common Stock | 12500.0 | | 12500 | D | |
Explanation of Responses: |
(1) | Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. |
(2) | The aggregate dollar value of the annual equity award to each Director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2021, the first day of the quarter, was $256.05, which resulted in a grant of 215 shares. |
(3) | Represents the closing price of the Issuer's common stock on July 1, 2021. |
(4) | The options are fully vested. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
WOLF DALE B 2180 HARVARD STREET SUITE 400 SACRAMENTO, CA 95815 | X |
|
|
|
Signatures
|
Jeff D. Barlow, by power of attorney for Dale B. Wolf. | | 7/2/2021 |
**Signature of Reporting Person | Date |
Molina Healthcare (NYSE:MOH)
Historical Stock Chart
From Aug 2024 to Sep 2024
Molina Healthcare (NYSE:MOH)
Historical Stock Chart
From Sep 2023 to Sep 2024